PDS Biotechnology Corp Files 8-K
Ticker: PDSB · Form: 8-K · Filed: Feb 24, 2025 · CIK: 1472091
| Field | Detail |
|---|---|
| Company | Pds Biotechnology Corp (PDSB) |
| Form Type | 8-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
PDS Biotech filed a standard 8-K, no major news.
AI Summary
PDS Biotechnology Corporation filed an 8-K on February 24, 2025, reporting on other events and financial statements/exhibits. The company, formerly Edge Therapeutics, Inc., is incorporated in Delaware and headquartered in Princeton, NJ. This filing does not contain specific financial details or significant event descriptions beyond its routine nature.
Why It Matters
This 8-K filing indicates routine corporate activity and financial reporting for PDS Biotechnology Corp, providing transparency to investors about their regulatory compliance.
Risk Assessment
Risk Level: low — The filing appears to be a routine 8-K with no disclosed material events, suggesting low immediate risk from this specific report.
Key Players & Entities
- PDS Biotechnology Corporation (company) — Registrant
- Edge Therapeutics, Inc. (company) — Former Company Name
- February 24, 2025 (date) — Date of Report
- Princeton, NJ (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for PDS Biotechnology Corporation?
This 8-K filing serves to report on 'Other Events' and 'Financial Statements and Exhibits' as of February 24, 2025.
When was PDS Biotechnology Corporation's report filed?
The report was filed on February 24, 2025.
What was PDS Biotechnology Corporation's former name?
PDS Biotechnology Corporation was formerly known as Edge Therapeutics, Inc.
Where are PDS Biotechnology Corporation's principal executive offices located?
The principal executive offices are located at 303A College Road East, Princeton, NJ 08540.
Under which section of the Securities Exchange Act is this 8-K filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding PDS Biotechnology Corp (PDSB).